Cancer Family
Digestive System Neoplasm
CI-CAN-00000012Explore in graph →
Non-malignant4,732 active trials43 approved drugs557 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000012Explore in graph →
Clinical trials
22,051 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03256201 | Exercise and Nutrition to Improve Pancreatic Cancer Outcomes | unknown | N/A | 95 | University of OklahomaOTHER | 1 | Aug 16, 2024 | clinicaltrials |
| NCT05867303 | A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors | unknown | Phase 1 | 48 | RemeGen Co., Ltd.INDUSTRY | 2 | Aug 16, 2024 | clinicaltrials |
| NCT05385250 |
| Bone-sparing Chemoradiotherapy for Anal Cancer - DACG-II(DACG-II) |
| unknown |
| N/A |
| 100 |
| Karen-Lise Garm SpindlerOTHER |
| 1 |
| Aug 15, 2024 |
| clinicaltrials |
| NCT06475170 | Preliminary Efficacy Analysis of 'λ+α' Double-Tract Reconstruction After Laparoscopic Proximal Gastrectomy | unknown | N/A | 60 | Northern Jiangsu People's HospitalOTHER | 1 | Aug 15, 2024 | clinicaltrials |
| NCT06540027 | The Effect of Minimally Invasive Surgery on Systemic Inflammatory Response in Rectal Cancer | unknown | — | 80 | Başakşehir Çam & Sakura City HospitalOTHER_GOV | 1 | Aug 15, 2024 | clinicaltrials |
| NCT05570279 | PLAN-A Data- Bio- and Plan- Bank Collection for SCCA in Denmark(PLAN-A) | unknown | — | 314 | Aarhus University HospitalOTHER | 1 | Aug 14, 2024 | clinicaltrials |
| NCT05833815 | Addition of Everolimus to Standard of Care in Carcinoma Gallbladder | unknown | Phase 2 / Phase 3 | 56 | Banaras Hindu UniversityOTHER | 1 | Aug 13, 2024 | clinicaltrials |
| NCT06463522 | Safety and Efficacy of Autologous Tumor-infiltrating Lymphocytes Therapy in Patients With Hepatocellular Carcinoma | unknown | Phase 1 / Phase 2 | 20 | Beijing 302 HospitalOTHER | 1 | Aug 13, 2024 | clinicaltrials |
| NCT06550063 | HER2 Status in Esophagogastric Adenocarcinoma and Its Associations With Patient's Clinicopathological Outcomes(HERA) | unknown | — | 2,188 | St. James's Hospital, IrelandOTHER | 1 | Aug 13, 2024 | clinicaltrials |
| NCT06248580 | Find HDV and Determine Its Status in Turkey(SITUHDVATION) | unknown | — | 20,000 | Yaşar Bayındır, MDOTHER | 1 | Aug 12, 2024 | clinicaltrials |
| NCT06006390 | CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 60 | Chongqing Precision Biotech Co., LtdINDUSTRY | 1 | Aug 9, 2024 | clinicaltrials |
| NCT06070636 | bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma | unknown | N/A | 30 | Sun Yat-sen UniversityOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT06259149 | A Study of Initiation Timing of VTE Prevention After Colorectal Cancer Surgery | unknown | — | 914 | RenJi HospitalOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT06339346 | Analysis of Histopathological Factors Predictive of Lymph Node Involvement and Management Practices in pT1 Colorectal Cancers Treated by Primary Endoscopic Resection(PROMOT1) | unknown | — | 400 | University Hospital, BrestOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT06341309 | Exploratory Study of Irinotecan Liposomes in Maintenance Therapy of Metastatic Colorectal Cancer | unknown | Phase 1 / Phase 2 | 20 | West China HospitalOTHER | 0 | Aug 9, 2024 | clinicaltrials |
| NCT06475326 | Adebrelimab in Combination With NALIRIFOX in Locally Advanced Pancreatic Cancer | unknown | Phase 2 | 87 | Fudan UniversityOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT06540430 | Digital Based Home Care Service for Ostomy Patients | unknown | N/A | 120 | Wonju Severance Christian HospitalOTHER | 0 | Aug 9, 2024 | clinicaltrials |
| NCT06543836 | ctDNA-guided Treatment of TKI Plus PD-1 Inhibitor for Advanced pMMR/MSS Colorectal Cancer | unknown | Phase 2 | 68 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT06545630 | Tumor Antigen-sensitized DC Vaccine for Colorectal Cancer Liver Metastases | unknown | Phase 1 | 10 | West China HospitalOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT06546280 | A Study of Camrelizumab Plus Apatinib as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Radical Resection or Ablation | unknown | Phase 2 | 38 | Zhujiang HospitalOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT04838327 | Rare Subtypes of Gastrointestinal Cancers | unknown | — | 130 | Aarhus University HospitalOTHER | 1 | Aug 7, 2024 | clinicaltrials |
| NCT05594927 | Icaritin Soft Capsule Versus Huachansu Tablet in the First-line Treatment of Unresectable Hepatocellular Carcinoma With Poor Conditions and Biomarker Enrichment (Biomarker Enrichment Study of Poor Prognosis HCC Patients, BESTPOP)(BESTPOP) | unknown | Phase 3 | 261 | Beijing Shenogen Biomedical Co., LtdINDUSTRY | 1 | Aug 7, 2024 | clinicaltrials |
| NCT06543030 | Transfemoral Versus Transradial Approach in Transarterial Chemoembolization of Hepatocellular Carcinoma | unknown | — | 60 | Assiut UniversityOTHER | 1 | Aug 7, 2024 | clinicaltrials |
| NCT02991677 | Exercise Effect on Chemotherapy-Induced Neuropathic Pain | unknown | N/A | 60 | Baltimore VA Medical CenterFED | 1 | Aug 6, 2024 | clinicaltrials |
| NCT04636008 | Sintilimab Plus Hypofractionated Radiotherapy for MSI-H/dMMR Rectal Cancer | unknown | Phase 1 / Phase 2 | 20 | West China HospitalOTHER | 1 | Aug 6, 2024 | clinicaltrials |
| NCT04716257 | A Prospective, Multi-center, Real-world Study of Ovarian Metastatic Colorectal Cancer Patients(proOMCRC) | unknown | — | 400 | West China HospitalOTHER | 1 | Aug 6, 2024 | clinicaltrials |
| NCT06498752 | MRD-Guided Consolidation Therapy Following Definitive Radiotherapy in Esophageal Cancer | unknown | Phase 2 | 102 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Aug 6, 2024 | clinicaltrials |
| NCT06539806 | Clinical Study Evaluating the Effect of Losartan | unknown | N/A | 90 | Tanta UniversityOTHER | 1 | Aug 6, 2024 | clinicaltrials |
| NCT06540508 | Application of Integrated Proteomic and Serum Metabolomic Analysis in Assessing the Efficacy and Prognosis of TACE Combined With Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma | unknown | — | 30 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Aug 6, 2024 | clinicaltrials |
| NCT05931068 | Perioperative Energy Expenditure in Major Liver Resection(PRO-NRG) | unknown | — | 20 | Academisch Ziekenhuis MaastrichtOTHER | 1 | Aug 5, 2024 | clinicaltrials |
| NCT06536712 | Effects of Exosome Adminstration in Preventing Early Leakage in Rectal Cancer Patients Undergoing Low Anterior Resection | unknown | Phase 1 | 20 | Tehran University of Medical SciencesOTHER | 1 | Aug 5, 2024 | clinicaltrials |
| NCT04220944 | Combined Locoregional Treatment With Immunotherapy for Unresectable HCC. | unknown | Phase 1 | 45 | Shanghai Zhongshan HospitalOTHER | 1 | Aug 1, 2024 | clinicaltrials |
| NCT04483284 | Study of TACE Combined With Camrelizumab in the Treatment of HCC Patients | unknown | Phase 2 | 28 | Shanghai Zhongshan HospitalOTHER | 1 | Aug 1, 2024 | clinicaltrials |
| NCT04149613 | Predictive and Prognostic Value of Inflammatory Markers and microRNA in Stage IV Colorectal Cancer | unknown | — | 100 | American University of Beirut Medical CenterOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT04454476 | Reversal of Preneoplastic Metaplasia in the Stomach With MEK Inhibitor | unknown | Phase 1 | 15 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT05412589 | mFOLFOX7 Plus Camrelizumab and Apatinib for Advanced HCC | unknown | Phase 2 | 35 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT06530784 | Cryoablation Combined With PD-1 Antibody and Bevacizumab for Hepatocellular Carcinoma | unknown | Phase 2 | 36 | Shanghai Zhongshan HospitalOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT05919758 | Value of Right-sided Hemicolectomy for Chldren With High-risk Neuroendocrine Tumors of the Appendix(NETkids) | unknown | — | 1,000 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Jul 30, 2024 | clinicaltrials |
| NCT06526832 | A Phase 1 Study of BST02 in Treating Locally Advanced Liver Cancer | unknown | Phase 1 | 9 | BioSyngen Pte LtdINDUSTRY | 1 | Jul 30, 2024 | clinicaltrials |
| NCT06527495 | Clinical Pharmacogenetic Study of Sorafenib in Egyptian Patients With Hepatocellular Carcinoma | unknown | Phase 1 / Phase 2 | 150 | Assiut UniversityOTHER | 1 | Jul 30, 2024 | clinicaltrials |
| NCT06528054 | TreatmENT of AnastomotiC LeakagE After COLON Cancer Resection(TENTACLE-Colon) | unknown | — | 2,000 | Radboud University Medical CenterOTHER | 0 | Jul 30, 2024 | clinicaltrials |
| NCT05638269 | A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China | unknown | — | 12,000 | Zhujiang HospitalOTHER | 1 | Jul 29, 2024 | clinicaltrials |
| NCT06521528 | A Pilot Clinical Study to Evaluate the Feasibility of Using the SPC Test | unknown | — | 237 | Novomics. Co., Ltd.INDUSTRY | 1 | Jul 29, 2024 | clinicaltrials |
| NCT06524362 | Effect of Pelvic Rehabilitation After Low Anterior Resection for Cancer Rectum. - A Randomised Controlled Trial(PERECARE) | unknown | N/A | 77 | GEM Hospital & Research CenterOTHER | 1 | Jul 29, 2024 | clinicaltrials |
| NCT06524557 | Exploration of Noninvasive Differential Diagnosis of Benign and Malignant Liver Tumors | unknown | — | 200 | Xijing HospitalOTHER | 1 | Jul 29, 2024 | clinicaltrials |
| NCT04823403 | Hepatic Intra-Arterial Administration of Ipilimumab in Combination With Intra-venous Nivolumab for Advanced Hepatocellular Carcinoma(HIPANIV) | unknown | Phase 1 | 27 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Jul 26, 2024 | clinicaltrials |
| NCT06521541 | Whole Course Multi-model Prehabilitation to Improve Clinical Outcome in Patients Undergoing Neoadjuvant Treatment Prior to Gastrectomy | unknown | N/A | 90 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | Jul 26, 2024 | clinicaltrials |
| NCT06522542 | Gastric Cancer Complicated With Bleeding | unknown | — | 200 | Peking University Third HospitalOTHER | 0 | Jul 26, 2024 | clinicaltrials |
| NCT06519006 | Effectiveness of Pelvic Floor Exercise to Prevent LARS (Low Anterior Resection Syndrome)(CH1) | unknown | N/A | 50 | F. D. Roosevelt University HospitalOTHER | 1 | Jul 25, 2024 | clinicaltrials |
Data updated 22 days agoSource updated Aug 16, 2024source: clinicaltrials